« Return to News | CROs/Service Providers

SIRO ClinPharm Partners with European Regulatory Expert

Thursday, September 24, 2009 09:26 AM

Indian CRO SIRO Clinpharm partnered with UK-based regulatory consulting firm Cambridge Regulatory Services (CambReg) to offer full regulatory services to clients conducting clinical trials in Europe. Services include the preparation of clinical trial applications, marketing authorizations, specialist paediatric investigation plans and paediatric use marketing authorizations.

SIRO Clinpharm has European offices in Germany, Romania, Estonia, Greece, Czech Republic and Spain, as well as offices in India, the U.S., Israel, and Europe.

"Our alliance with CambReg would go a long way in helping small and mid-sized companies cut through the regulatory maze in Europe" said SIRO Clinpharm’s chief operating officer, Chetan Tamhankar, in a statement. "This alliance builds on the strength of our European clinical trial operations and allows us to offer greater value to our clients."

CambReg offers regulatory compliance advice and submissions services to clients in Asia, Europe and the U.S.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.